Business Description
For sale is a company that offers event planning for conferences, corporate meetings, and special events in the pharmaceutical and healthcare market. The company has served clients for over 25 years and built a team of 29 event planning professionals and administrative support staff.
For conference and meeting management, the company acts as a collaborative extension of the client by applying their knowledge, skills, and expertise to enhance and grow the client’s events. Areas of event planning include everything from a private luncheon for two, to large corporate meetings for hundreds, to association conferences with thousands of attendees. This work also includes the planning and facilitation of exhibit booths, sponsorships, and Product Theaters. In addition, the team of specialists supports clients in planning and managing future events by bringing fresh ideas, over 25 years of experience, and proven results.
The company focuses on retaining current clients and brings on new clients at a steady pace. To date, 95% of its total revenue is from recurring contracts and 5% from new or one-time contracts. Most contracts are 3-5 years with automatic renewal year over year. Total revenue for services is 45% Conference Planning for Associations, 40% Corporate Planning for meetings, 10% for Special events, and 5% for Promotional items. Although revenue and earnings were down during the pandemic, the company managed to retain most of its revenue through a pivot to online events and other client support work. In addition, the business was able to retain its full staff through the pandemic, allowing it to pick up at regular capacity as face-to-face events started up again.
The business has grown organically through word-of-mouth and referrals. Several key employees are in place to help the new owner with a smooth transition and have the skills for promotion to cover the existing owner’s responsibilities. This deal is SBA prequalified with a lender for an approved buyer.
| FY 2020 | FY 2021 | FY 2022 | FY 2023 Q1 | |
| Revenue | $3,527,278 | $2,892,004 | $3,790,095 | $1,312,705 |
| EBITDA | $1,076,588 | $570,417 | $1,126,221 | $459,210 |